Samsung Medical Center
The Ewing's sarcoma treatment cost in Republic of Korea typically includes a PET/CT scan that runs from Price on request to Price on request and primary Sarcoma surgery which ranges from $7,600 to $12,400. Total expenses depend on the cancer stage, required chemotherapy cycles, and the specific hospital tier. Patients can achieve 30-50% savings compared to the US. Most specialized care is concentrated in Seoul.
Typical Ewing's Sarcoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: For patients requiring high-precision tumor removal, Seoul National University Bundang Hospital (SNUBH) is ideal. They utilize the digital BESTcare system to minimize surgical errors. Samsung Medical Center is best for advanced cases. It features presidential-standard care and technologies like the Da Vinci surgical system. Asan Medical Center offers a multidisciplinary approach for complex oncology, treating over 11,800 outpatients daily.
| Republic of Korea | Turkey | Austria | |
| Sarcoma surgery | from $7,600 | from $10,000 | from $35,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Radiation Therapy for Sarcomas | - | from $3,250 | from $18,000 |
| Complex treatment of Ewing's sarcoma | - | from $30,000 | from $55,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Ewing's sarcoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ewing's sarcoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ewing's sarcoma treatment journey.
The doctor is the Head of the Radiation Oncology Department and has an extensive background in oncology, having completed specialty training at Samsung Medical Center and Seoul National University Hospital. The doctor graduated from Seoul National University College of Medicine and specializes in the treatment of stomach cancer, pancreaticobiliary cancer, CNS tumors, pediatric tumors, sarcomas, and hematologic cancers.
Samsung Medical Center, Seoul National University Hospital, and Asan Medical Center are the premier institutions for Ewing's sarcoma in Korea. These centers offer integrated multidisciplinary care. They utilize advanced PET-CT diagnostics and limb-sparing surgical techniques. Specialized sarcoma teams ensure precise treatment for rare bone tumors.
Bookimed Expert Insight: While hospital reputation matters, patient data highlights volume as the key quality indicator. Asan Medical Center performs over 65,000 surgeries annually. This high frequency with complex procedures typically correlates with better outcomes for rare cancers. Specialized teams at these major Seoul centers handle the highest density of rare sarcoma cases nationwide.
Patient Consensus: Patients emphasize choosing large tertiary centers over general hospitals for this specific diagnosis. They strongly recommend bringing original biopsy slides and imaging for a second pathology review.
The 5-year survival rate for Ewing's sarcoma in South Korea is approximately 52% overall. Pediatric patients show better outcomes with a 75% survival rate. Adolescents and young adults maintain a 51% survival rate. Success depends on the tumor stage and receiving multidisciplinary care at JCI or KOIHA-accredited centers.
Bookimed Expert Insight: While national averages hover around 52%, high-volume centers like Asan Medical Center perform over 65,000 operations annually. These major institutions often handle more complex cases than smaller facilities. Patients should look for centers with Newsweek-ranked oncology departments. These hospitals typically have dedicated sarcoma teams to manage rare bone cancers more effectively.
Patient Consensus: Patients emphasize finding a hospital with a specific sarcoma team rather than general oncology. They note that survival depends heavily on whether surgeons can remove the tumor cleanly and whether the cancer has spread at diagnosis.
Ewing's sarcoma treatment in Korea utilizes a multidisciplinary approach combining high-dose chemotherapy with localized surgery or advanced radiation. Major Seoul-based tertiary centers utilize Newsweek-ranked oncology departments. These facilities provide systemic drug protocols alongside digital surgical systems to ensure precise tumor removal and limb preservation.
Bookimed Expert Insight: Korea's leading tertiary hospitals manage massive patient volumes, with Samsung Medical Center seeing over 2,000,000 patients annually. This high throughput is a direct quality signal for rare cancers like Ewing's sarcoma. It ensures that surgical teams maintain peak proficiency in complex resections. Choosing these high-volume centers in Seoul provides access to multidisciplinary tumor boards that meet Newsweek's global excellence standards.
Patient Consensus: Patients emphasize that receiving care at a major university hospital is vital due to the disease's complexity. They note that managing chemotherapy side effects requires strong supportive care and experienced nursing teams.
Proton beam therapy is available for Ewing's sarcoma in Korea at specialized oncology centers in Seoul. Facilities like Samsung Medical Center utilize this advanced radiation to treat tumors while protecting healthy organs. It is particularly valuable for pediatric cases and tumors located near sensitive structures.
Bookimed Expert Insight: While several Seoul hospitals treat sarcoma, Samsung Medical Center is a standout choice because it combines proton therapy with nearly 2,000,000 annual patient visits. This massive patient volume ensures surgeons and radiologists have deep experience with rare bone tumors. If you are looking for advanced radiotherapy, focusing on centers with verified JCI-level accreditations in Seoul provides the highest safety standards.
Patient Consensus: Patients note that proton therapy is a specialized option often requiring specific referrals. They emphasize checking if tumor location warrants radiation sparing before arranging travel to Seoul centers.
Seeking a second opinion for Ewing sarcoma in South Korea is standard practice for confirming diagnostic accuracy and treatment sequencing. Major Seoul-based tertiary centers utilize multidisciplinary tumor boards and specialized pathology reviews to ensure limb-sparing surgery options and precise radiation protocols are prioritized for patients.
Bookimed Expert Insight: Clinical volume is the strongest indicator of success for rare bone cancers in Seoul. Asan Medical Center treats over 11,000 outpatients daily. Specialized oncology centers like Samsung Medical Center provide integrated care. Choosing a high-volume facility ensures your case reaches a dedicated sarcoma board rather than a general surgeon.
Patient Consensus: Patients emphasize that initial treatment plans often vary significantly between hospitals regarding surgery versus radiation. It is vital to bring a complete packet including pathology blocks and imaging discs to avoid any diagnostic delays.
South Korean hospitals treat Ewing's sarcoma using a multimodal approach. This combines intensive systemic chemotherapy with surgery or radiation. Major Seoul centres perform complex limb-salvage operations. They use imaging to secure clear margins while preserving function. Treatment typically lasts 6 to 9 months.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and houses Asia's largest cancer centre. This high volume allows for 17 disease-specific departments. Such specialisation helps South Korean teams manage rare sarcomas with high precision. Asan Medical Center also provides personal coordinators. This supports Australian patients through complex surgical and recovery phases.
Patient Consensus: Patients note that treatment involves months of therapy even after successful surgery. Clear surgical margins are essential for long-term recovery in South Korea. Teams often prioritise reconstruction and limb preservation over amputation when the tumour location allows.
Samsung Medical Center and Asan Medical Center are leading choices for Ewing's sarcoma treatment. They are located in South Korea. These Seoul-based hubs use proton beam therapy and multidisciplinary teams. They hold Korean Institute for Healthcare Accreditation (KOIHA) and Newsweek rankings. This means they meet high standards for complex bone cancer cases.
Bookimed Expert Insight: While major Seoul hospitals offer similar clinical quality, international patient infrastructure varies. Asan Medical Center stands out by assigning a personal coordinator to every international patient. This support is vital for Ewing's sarcoma, because treatment often involves complex, multi-stage protocols. These require constant communication between oncology and orthopaedic teams.
Patient Consensus: Patients note that Seoul's major university hospitals provide elite cancer care. However, they can be very busy. Those travelling to South Korea suggest choosing centres with dedicated international clinics. These handle appointments and English translation more efficiently.
The 5-year overall survival rate for Ewing's sarcoma in South Korea is 52% across all ages. Paediatric patients under 15 show a 75% survival rate. Major Seoul hospitals use multidisciplinary teams. They also use technologies like proton beam therapy and Gamma Knife for these complex bone tumours.
Bookimed Expert Insight: Samsung Medical Center serves over 2 million outpatients annually. It also operates Asia’s largest cancer centre. Korean specialists see rare Ewing's cases more frequently than many Western regional centres. This is because of the massive patient volume. Their use of real-time digital image sharing between oncologists and surgeons helps speed up critical treatment decisions.
Patient Consensus: Patients value the speed of diagnosis in Seoul, noting that PET-CT and biopsies happen quickly. Many highlight the helpfulness of personal coordinators at major hospitals. These coordinators assist with medical translations during oncologist appointments.
South Korea offers radiation therapy for Ewing's sarcoma through specialised oncology centres in Seoul. Facilities such as Samsung Medical Center and Soon Chun Hyang University Hospital provide proton beam therapy and Tomotherapy. These precise techniques target tumours while sparing healthy tissues and surrounding organs.
Bookimed Expert Insight: South Korea's oncology landscape is defined by massive patient volumes and digital integration. Samsung Medical Center treats over 2,000,000 outpatients annually and partners with the Mayo Clinic. For Ewing's sarcoma patients, this means access to centres with 17 disease-specific departments. This scale allows specialists to manage thousands of complex cases. They do so with high precision and safety.
Patient Consensus: Patients find radiation manageable but tiring. They emphasise that proton therapy is particularly helpful for tumours near critical organs. In South Korea, coordinating care is simplified by dedicated international units. These units assist with travel and billing.
South Korean medical centres provide autologous stem cell transplantation. This treats relapsed or refractory Ewing's sarcoma. This procedure usually follows high-dose chemotherapy to help the bone marrow recover. Specialists at Samsung Medical Center or Asan Medical Center evaluate cases based on chemo-sensitivity.
Bookimed Expert Insight: Many centres offer stem cell transplants. However, for Ewing's sarcoma relapse, expertise is concentrated in Seoul's multi-disciplinary centres. Asan Medical Center performs over 65,000 surgeries annually. It maintains some of South Korea's highest success rates for complex procedures. This high volume often leads to better results. This applies especially to rare paediatric and adolescent bone tumours.
Patient Consensus: Patients find that South Korean hospitals offer more personalised protocols. This goes beyond a simple yes or no answer. They suggest confirming if the transplant is routine or trial-based. Eligibility often depends on how well the relapse responds to initial salvage chemotherapy.
South Korean oncology centres treat Ewing's sarcoma using intensive multi-agent chemotherapy. Primary protocols typically alternate between vincristine, doxorubicin, and cyclophosphamide (VDC) and ifosfamide and etoposide (IE). Major Seoul hospitals like Samsung Medical Centre follow these international standards. This allows them to treat both localised and metastatic cases efficiently.
Bookimed Expert Insight: Samsung Medical Centre and Asan Medical Centre perform over 45,000 and 65,000 annual surgeries respectively. Their high patient volumes mean oncologists there handle rare Ewing's cases more frequently. They see more of these cases than doctors at smaller regional hospitals. This experience often leads to more precise side-effect management. This is especially true during long 14-cycle chemotherapy protocols.
Patient Consensus: Patients note that doxorubicin and ifosfamide phases cause the most significant side effects. They recommend discussing anti-nausea plans early. This is because reactions differ between drug cycles in South Korea.
International patients can receive Ewing's sarcoma treatment in South Korea. Major Seoul-based medical centres provide comprehensive surgery, chemotherapy, and proton beam therapy. These clinics hold JCI or KOIHA accreditations. They often manage over 45,000 surgeries yearly with specialised oncology departments.
Bookimed Expert Insight: While many oncology centres exist, Samsung Medical Center stands out. It is Asia's largest cancer centre, with 17 disease-specific departments. This clinical depth means patients with rare Ewing's sarcoma access teams who manage high volumes of complex cases. This level of specialisation is rarely found outside major global hubs.
Patient Consensus: Patients recommend contacting Seoul university hospitals early and sending pathology slides before travelling. Reliable translation support and help with foreign insurance billing make the process smoother in South Korea.